2004
DOI: 10.1002/chin.200408129
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Bis‐pyridinium Oxime Antidotes Using Bis(methylsulfonoxymethyl) Ether for Organophosphate Nerve Agents.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
0

Year Published

2004
2004
2012
2012

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(20 citation statements)
references
References 1 publication
2
18
0
Order By: Relevance
“…The yields of four former known compounds (6c, 8a-c) are comparable with published data [12][13][14][15]. Unfortunately, this system was not applicable in the case of 2,2 0 -bis(hydroxyiminomethyl)-1,1 0 -(1,3-phenylenedimethyl)-bispyridinium dibromide (6b), where other conditions were used (Scheme 4) [16].…”
Section: Resultssupporting
confidence: 84%
“…The yields of four former known compounds (6c, 8a-c) are comparable with published data [12][13][14][15]. Unfortunately, this system was not applicable in the case of 2,2 0 -bis(hydroxyiminomethyl)-1,1 0 -(1,3-phenylenedimethyl)-bispyridinium dibromide (6b), where other conditions were used (Scheme 4) [16].…”
Section: Resultssupporting
confidence: 84%
“…Pralidoxime and obidoxime were purchased from Léciva (Czech Republic) from Merck (Germany). H-oxime HI-6 was synthesized by Dr Bielavsky earlier at our department, using a standard synthetic approach (Yang et al, 2003). The respective chemical structures are given in figure 1.…”
Section: Chemicalsmentioning
confidence: 99%
“…Unfortunately, this approach only protects against a few LD 50 nerve agents [19]. If the amount of nerve agents exceeds the tolerable dose, AChE reactivators (as the causal antidotes) are still required, and so the development of new and more potent AChE reactivators continues [20][21][22][23].…”
Section: Discussionmentioning
confidence: 99%